Clinical studies prove that taking diet supplements, with a high content of L-carnitine, in a comprehensive way protects the proper functioning of the cardiovascular system
However, in people with Crohn's disease, distinguishing between medication side effects and disease flares can be challenging
A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss
What type of program is Noom
Evidence & References GLP-1 receptor agonists may reduce metastatic progression of certain obesity-related cancers